Skip to main content
20 April 2024
Last updated:
Thursday 18 April 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Hot targets in immuno-oncology
Read more
The Bispecific Approach, Interviews with Merus, Genmab and NovalGen
Read more
Why we should take a second look at RNA therapeutics
Read more
Technology Transfer: Partnering with the US National Cancer Institute
Read more
Building biotech using an oncology network
Read more
Drug development robust, despite the pandemic
Read more
Developing radionuclide PARP inhibitors
Read more
The linker matters in antibody-drug conjugates
Read more
The hunt for the perfect tumour-associated antigen
Read more
Oncology approvals are on an upward trend
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Page
3
Current page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form